Elsevier appoints Stuart Whayman as President of Corporate Markets

Elsevier, a global leader in scientific information and analytics, announced today the appointment of Stuart Whayman as President of Corporate Markets effective January 6, 2025. Mr. Whayman will report to Kumsal Bayazit, CEO of Elsevier, and will lead the global business that provides advanced scientific and technical information, data and decision support solutions for innovation to R&D-focused organizations across various industries, including pharmaceuticals and chemicals.

Mr. Whayman joined Elsevier in 2014, initially as Chief Financial Officer and later served as Chief Commercial Officer. Most recently he was Managing Director of the Researchers and Librarians business segment, leading a cross-functional global team supporting academic research institutions. He played a key role in developing new innovative solutions for researchers, combining generative AI, trusted content, and data sets. He previously held senior roles in finance at RELX, Elsevier’s parent company, and at RBI, now part of the LexisNexis Risk division, having joined the group in 1998.

Kumsal Bayazit, CEO of Elsevier, said: “Stuart brings exceptional global leadership experience and a proven track record of driving positive outcomes for our customers. His deep knowledge of combining trusted content and data sets with responsible technologies and AI is invaluable during this time of accelerated technological change in the R&D environment.”

In addition to his commercial and management responsibilities, Stuart will continue to serve as the Executive Sponsor of our Climate Action Program and as Co-Chair of Elsevier’s Climate Advisory Board.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.